Total planned funding: $405,145,231
Clear active filters
Ethiopia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Ethiopia | $405,145,231 |
Organizational Types
| Host Country Government Agency | $111,832,922 |
| Private Contractor | $75,711,958 |
| Unknown | $64,100,229 |
| University | $45,304,685 |
| Own Agency | $38,505,695 |
| NGO | $34,652,108 |
| Implementing Agency | $29,341,413 |
| Multi-lateral Agency | $4,365,296 |
| Other USG Agency | $1,330,925 |
| FBO | $0 |
Program Areas
| Treatment | $162,909,893 |
| Care | $98,604,171 |
| Governance and Systems | $51,937,778 |
| Prevention | $37,551,409 |
| Testing | $30,890,039 |
| Management and Operations | $23,251,941 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $137,525,052 |
| HKID: Care: Orphans and Vulnerable Children | $44,803,148 |
| HBHC: Care: Adult Care and Support | $32,948,770 |
| HVCT: Testing: HIV Testing and Counseling | $30,890,039 |
| HVMS: Management and Operations | $23,251,941 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $20,764,044 |
| OHSS: Health Systems Strengthening | $20,535,975 |
| HVSI: Strategic Information | $18,473,388 |
| PDTX: Treatment: Pediatric Treatment | $13,389,184 |
| HLAB: Laboratory Infrastructure | $12,928,415 |
| HVTB: Care: TB/HIV | $12,234,493 |
| HTXD: Treatment: ARV Drugs | $11,995,657 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,019,403 |
| PDCS: Care: Pediatric Care and Support | $8,617,760 |
| HMBL: Biomedical Prevention: Blood Safety | $3,449,663 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,351,182 |
| HMIN: Biomedical Prevention: Injection Safety | $878,458 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $79,850 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,809 |
Top Partner Programs
Not Available:
$59,208,183
Countries/Regions
Columbia University:
$39,073,623
Countries/Regions
Chemonics International:
$36,530,044
Countries/Regions